Table 1.
Vitiligo and/or AA | cGvHD Involvement | |||||||
---|---|---|---|---|---|---|---|---|
Patient No./Sexa,b,c | Disease | Transplant Conditioning | Graft Type | Time to Occurrence, mo | Distribution | Vitiligo Type | Skin | Other Organs |
1/M | CML | Bu/Cyc | BM | 24 | Perioral, torso, R buttock, pretibial legs | Torso | Epid | Eyes, lungs, liver |
2/M | APL | … | PB | … | Periorbital/oral, head/neck, back, fingers | Classicd | Bothe | Eyes, oral, GI |
3/F | FNHL | Flu/Cyc | PB | … | Periorbital, perioral, L cheek, back | Classicd | Epid | Eyes |
4/M | RMSA | Flu/Cyc/Mel | PB | … | B/L cheeks, head/neck, upper chest, UE, LE | Generalized | Bothe | Eyes, oral, lungs, joint |
5/M | CML | Bu/Cyc/VP-16 | BM | … | Perioral | Classicd | Bothe | Eyes, oral, GI, joint |
6/M | CML | Bu/Flu/ATG | BM | 36 | Perioral, cheeks, acral, UE, genitalia | Classicd | Bothe | Eyes, oral, GI, liver, genital |
7/F | CML | Bu/Flu/ATG | PB | … | Trichrome face, chest, upper back, B/L thighs | Classicd | None | Eyes, oral, lungs, GI, joint |
8/Ma,b | WAS | … | Cord | … | Diffuse trichrome vitiligo | Generalized | Bothe | Lungs, joint |
9/F | AML | Flu/TBI | PB | 36 | Face, chest, lower back, B/LUE, LE | Generalized | Scl | Eyes, oral, lungs, GI, joint |
10/Fb,c | AML | Flu/Cyc/TBI | Cord | … | Vitiligo: face, postauricular, neck, trunk, UE, LE AA: scalp vertex | Generalized | Epid | Lungs, vulvovaginal |
11/M | CLL | Flu/Cyc | PB | … | Face, scalp, neck, anterior trunk | Generalized | Bothe | Eyes, oral, liver, joint |
12/M | B-cell ALL | Cyc/TBI | PB | … | Periorbital, perioral, scalp, chin | Classicd | Epid | Oral, lungs |
13/F | CTCL | Flu/Mel | PB | … | Neck, trunk, proximal UE | Torso | Bothe | Eyes, lungs, GI, liver, genital |
14/M | CML | Bu/Cyc | PB | 84 | Trichrome face, trunk, B/LUE | Generalized | Bothe | Eyes, oral, lungs, liver |
15/Mc | ALL | Cyc/VP-16/TBI | BM | 24 | Scalp | NA | None | Lungs, GI |
Abbreviations: AA, alopecia areata; ALL, acute lymphoblastic leukemia; AML, acute myelogenous leukemia; APL, acute promyelocytic leukemia; ATG, antithymocyte globulin; B/L, bilateral; BM, bone marrow; Bu, busulfan; cGvHD, chronic graft-vs-host disease; CLL, chronic lymphocytic leukemia; CML, chronic myelogenous leukemia; CTCL, cutaneous T-cell lymphoma; Cyc, cyclophosphamide; epid, epidermal; Flu, fludarabine; FNHL, follicular non-Hodgkin lymphoma; GI, gastrointestinal tract; L, left; LE, lower extremities; Mel; melphalan; NA, not applicable; PB, peripheral blood; R, right; RMSA, rhabdomyosarcoma; Scl, sclerotic; TBI, total body irradiation; UE, upper extremities; VP-16, etoposide; WAS, Wiskott-Aldrich syndrome; …, not known.
All patients whose donor sex was known received transplants from female donors; donor sex for patient 8 was not reported.
Thirteen of the 15 patients had an HLA-identical donor; a mismatch occurred only with patients 8 and 10.
Thirteen of the 15 patients had only vitiligo; patient 10 had both vitiligo and AA; patient 15 had only AA.
Classic indicates predominantly perioral, periorbital, and acrofacial involvement; torso, predominantly truncal involvement; generalized, diffuse involvement.
Both indicates both sclerotic and epidermal cGvHD involvement.